Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.

@article{Vignolo1991StaturalGA,
  title={Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.},
  author={M. Florencia Vignolo and Shirin Milani and Bruno Pietro Imbimbo and Arturo Naselli and Eliana Di Battista and Giorgio Piaggio and L Leveratto and Giuseppe Morreale and Mirko Sardella and Mireille Corsini},
  journal={Clinical and experimental rheumatology},
  year={1991},
  volume={9 Suppl 6},
  pages={
          41-5
        }
}
Deflazacort, a new glucocorticoid (DFZ) which has recently become available, is known to have lower adverse effects on the skeletal metabolism and is expected to inhibit growth to a lesser extent in long-term treated children than earlier cortisone analogues. With the aim of verifying this hypothesis a multicenter study was planned to compare the effects of deflazacort and prednisone on linear growth and skeletal maturation in a group of prepubertal children requiring chronic steroid therapy… CONTINUE READING

Similar Papers